Skip to content

Alpha Cognition ACOG Allocationof Proceedsto Warrant Liabilities

Allocationof Proceedsto Warrant Liabilities at other companies

Archer Aviation logo
Archer AviationACHR
$7.1M-85.1%
Intuitive Machines, Inc. logo
Intuitive Machines, Inc.LUNR
$69.82M+171%
Bakkt
 logo
Bakkt BKKT
$12.03M-18.0%
SLD
Solid PowerSLDP
$4.24M+48.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$9.58M-46.2%
Nuvation Bio logo
Nuvation BioNUVB
$0-100%

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept acog:AllocationofProceedstoWarrantLiabilities.

The official record: Alpha Cognition’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's allocationof proceedsto warrant liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's allocationof proceedsto warrant liabilities?
Alpha Cognition (ACOG) reported allocationof proceedsto warrant liabilities of $513.37K in Q4 2024.
What does allocationof proceedsto warrant liabilities mean?
The portion of capital raised from financing activities that is attributed to the fair value of warrant liabilities rather than equity. This classification is significant for understanding the company's capital structure and the potential for future cash outflows or dilution. It reflects the accounting treatment of complex financial instruments issued alongside capital raises.